Latest Breaking News On - Independent board chairman - Page 1 : comparemela.com

Form DEF 14A ORACLE CORP For: Nov 15

Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs

$10.50 Per Share All-Cash Transaction Represents a Significant Premium for Tabula Rasa Stockholders Combination of Two Highly Complementary Companies to Benefit Patients, Providers and Payers with.

Dow announces results from 2023 Annual Stockholder Meeting

Magnolia Founder, Longtime Oxy Chief Chazen Remembered for 'Profound' Impact on Oil, Gas Industry

Stephen Chazen, the former chief executive of Magnolia Oil & Gas Corp., has passed away, the independent exploration and production company (E&P)

QUANTRO Therapeutics appoints Dr. Elmar Maier as Independent Board Chairman

DGAP-News: QUANTRO Therapeutics GmbH / Key word(s): Personnel 30.04.2021 / 10:00 QUANTRO Therapeutics appoints  Dr. Elmar Maier as Independent Board Chairman Vienna, Austria, 30 April 2021: QUANTRO Therapeutics GmbH today announced the appointment of Dr. Elmar Maier as Independent Chairman of its Board. Elmar has a long-standing track record as a seasoned dealmaker in the life science industry. Over the last 26 years, he has co-founded several biotech companies (including GPC Biotech AG and iOmx Therapeutics AG) and held C-level positions on multiple management teams in private and public biotech companies. He has helped biotech companies to establish large R&D collaborations generating several hundred million dollars cash up-front, raise significant equity funding and execute M&A transactions. Elmar holds a degree in chemistry and obtained his Ph.D. from the University of Konstanz, Germany. He was a scientist at the ICRF Laboratories in London and Department Head at the Ma